avonex
(interferon beta-1a)Biogen Inc.
Usage: AVONEX is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
9 results
byooviz
(ranibizumab-nuna)BIOGEN INC.Usage: BYOOVIZ is indicated for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).opuviz
(Aflibercept-Yszy)Biogen Inc.plegridy
(peginterferon beta-1a)Biogen Inc.Usage: PLEGRIDY is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive MS.qalsody
(tofersen)Biogen Inc.Usage: QALSODY is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults with a superoxide dismutase 1 (SOD1) gene mutation. Approval is based on reduced plasma neurofilament light chain (NfL) levels, with continued approval pending verification of clinical benefit from further trials.tecfidera
(dimethyl fumarate)Biogen Inc.Usage: TECFIDERA is indicated for treating relapsing forms of multiple sclerosis in adults, which includes clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.tofidence
(TOCILIZUMAB)Biogen Inc.Usage: TOFIDENCE™ (tocilizumab-bavi) is indicated for treating moderately to severely active rheumatoid arthritis in adults who have not responded adequately to DMARDs, as well as active polyarticular and systemic juvenile idiopathic arthritis in patients aged 2 years and older.tysabri
(natalizumab)Biogen Inc.Usage: TYSABRI is indicated for the treatment of relapsing forms of multiple sclerosis in adults and for inducing and maintaining clinical response in adults with moderately to severely active Crohn's disease, who have not adequately responded to or cannot tolerate conventional therapies. Risks should be carefully considered.vumerity
(diroximel fumarate)Biogen Inc.Usage: VUMERITY is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.